DaveFinlayTCD @finlayd@qoto.org

RT @tcddublin
Professor Cliona O'Farrelly has today been named a 2022 @aaas Fellow. Cliona has been honoured for her outstanding achievements as a researcher in the field of comparative immunology.

Read more at: https://bit.ly/3jjlGdb

RT @LindaDoyle
It's been a great week on the @ERC_Research front with two Trinity researchers winning Proof of Concept Grants and another two winning Consolidator Grants!

Congratulations everyone 🎉

👉 https://bit.ly/3Ht3EhY
👉 http://bit.ly/40ehZGm

RT @LindaDoyle

RT @TrinityMed1
Exciting news for the school this morning with the announcement of @SDoyleTcd's award from the @ERC_Research for her ground-breaking investigations for novel immunotherapies to fight blindness. Congratulations Sarah! Read more about Sarah's research here: https://bit.ly/3JBdQGm

RT @MolecularTcd
📢#jobalert Looking for a Postdoctoral Fellow to join the team!
Translational project to identify early molecular signatures which might predict onset of #RheumatoidArthritis
Deadline: 31st Jan 2023.
🔗https://rheumatologytcd.com/
🔗https://arthritissvuh.com/home/
RT appreciated

RT @ImmPRes_
did you notice that in the last release we added a feature to study protein families. For example, how about looking at the glycolytic proteins and how they change upon T cell activation in CD8s? #glycolysis #tcells #proteomics

Easily done in the heatmap section 😎

RT @tcdflow
We're hiring an RA to work with me and Prof. Jean Fletcher (#flowcytometry and translational #immunology) in @tcdTBSI through the COVID-19 Immunology Research Hub. Please spread the word! Deadline Friday week... #hiring #immunologyjobs

RT @SNI_NKMeeting
Registration is now open for #NK2023! Welcome to the north on September 26-29, we look forward to hosting you in Oslo, Norway and learn and discuss everything new about NK cells! http://nk2023.org/registration

RT @OSheaHoganLab
And unopposed marketing goes on. Need a public health obesity act. Happy Easter.

RT @metab_innate
🚨Last weeks #immunometabolism findings🚨@Bims_BiomedNews ⬇️⬇️⬇️

http://biomed.news/bims-imicid/2023-01-15

My highlights:
I) @DoctorKvoss & @JeffRathmell find T cell impairment in SLE arises from elevated Transferrin receptor & iron uptake @SciImmunology
II) GOT1 & CD8+ T cells @CellReports

RT @dr_p_g
Heads up! Macrophages influence DC (and their own) metabolism through nitric oxide. A cautionary tale for GM-CSF-derived DC cultures!

Check out the paper by Lucía @luminarrieta and Janet from the Berod lab @luberod

https://onlinelibrary.wiley.com/doi/10.1002/eji.202149691

RT @metab_innate
🚨Last weeks #immunometabolism discoveries @Bims_BiomedNews ⬇️⬇️⬇️

http://biomed.news/bims-imicid/2023-01-08

My highlights:

I) Microbial metabolite harmaline protects systemic inflammation via bile acid-GPR5 signalling
II) Sphingosine synthesis and S1P promote mito fission and trained immunity

RT @ImmPRes_
flurry of updates coming your way. First up: Bach2 deletion can create super killer cytotoxic T lymphocytes. How do you ask? well it causes a massive increase in granzymes and perforin. This data from the @griffiths_lab is now up on ImmPRes #tcells #superkillers

RT @OnkTherapeutics
We’ve been named as one of BioSpaces’s NextGen 'Class of 2023', designating us as one of the most promising new life sciences companies in N.America this year. We’re driven by our purpose of pioneering optimally engineered #NKcell therapies to cure cancer.
https://www.onktherapeutics.com/onk-therapeutics-named-most-promising-company-in-biospaces-nextgen-2023-list/